Signal
Single-cell and proteomic analyses reveal regulatory hubs and heterogeneity in tumor microenvironments
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-08-18 15:08 UTCUpdated 2026-08-19 10:58 UTC
rss
clinical_trialsr_and_dsafety_signals
Trend in the last 24h
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Coverage centers on: bioRxiv (all subjects).
Entities
Odubote, M. O.Emeribe, C. E.Yavuz, B. R.Jang, H.Nussinov, R.Yan, H.Demeulemeester, J.Verfaillie, A.
Score total
1.16
Momentum 24h
4
Posts
4
Origins
1
Source types
1
Duplicate ratio
0%
Why now
- Recent advances in single-cell and spatial multi-omics enable unprecedented resolution of tumor ecosystems.
- New integrative analyses highlight conserved signaling pathways across multiple tumor types.
- Emerging data provide actionable insights to improve clinical outcomes in challenging cancers.
Why it matters
- Understanding tumor heterogeneity and microenvironmental regulation is critical for developing effective targeted therapies.
- Identifying central regulatory hubs like STAT3 and HIF-1 can guide rational drug combination strategies.
- Mapping tumor evolution and fibroblast programs reveals new therapeutic vulnerabilities in diverse cancers.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: medium
Recurring claims
- STAT3, NF-κB, MYC, and HIF-1 act as central regulatory hubs coordinating tumor-associated transcriptional programs.
- HIF-1 signaling is a dominant recurrent pathway across malignant cells in untreated breast tumors, suggesting a shared hypoxia-adaptive program.
- Chromosomal instability drives spatial and temporal phenotypic diversity in malignant peripheral nerve sheath tumors, linking genotype to phenotype.
- Cancer-associated fibroblasts in head and neck cancer exhibit heterogeneity and plasticity, with conserved extracellular matrix remodeling features that are targetable.
How sources frame it
- Odubote, M. O., Emeribe, C. E.: neutral
- Yavuz, B. R., Jang, H., Nussinov, R.: neutral
- Yan, H., Demeulemeester, J., Verfaillie, A., Et Al.: neutral
- Prieto-Fernandez, L., Martinez-Carrillo, A., De...: neutral
Consolidated recent preclinical research highlighting tumor microenvironment complexity and regulatory networks relevant for drug development.
All evidence
All evidence
Functional proteomics identifies targetable cancer-associated fibroblast programs in head and neck cancer
bioRxiv (all subjects) · biorxiv.org · 2026-08-19 10:58 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
- bioRxiv (all subjects) (1)
Top origin domains (this list)
- biorxiv.org (1)